Jan 20, 2010
Judge Rules in Favor of Plaintiffs’ Experts in Hormone Replacement Therapy Cases
A Philadelphia judge has ruled that the scientific methodologies used by key plaintiffs’ expert witnesses in the 1,500 cases pending in mass tort litigation over hormone replacement therapy are not novel and are admissible in court. Philadelphia Common Pleas Judge Sandra Mazer Moss ruled from the bench Wednesday against a defense motion that challenged the differential diagnosis methodology used by plaintiffs’ expert witnesses to evaluate whether they think HRT was a substantial factor in causing a plaintiff’s cancer.